Trademarkia Logo

Canada

C$
Trademark Search in Canada
RETHYMIC

View On IC.GC.CA

RETHYMIC
REGISTERED

on 31 Aug 2023

Last Applicant/ Owned by

ENZYVANT THERAPEUTICS GMBH

Viaduktstrasse 84051 Basel

CH

Serial Number

1949669 filed on 5th Mar 2019

Registration Number

TMA1196243 registered on 31st Aug 2023

Registration expiry Date

31st Aug 2033

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

RETHYMIC

Trademark usage description

pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and i Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; Pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto;

Classification kind code

12

Mark Details

Serial Number

1949669

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 30th Aug 2023		Registration Pending
Submitted for opposition 191
on 30th Aug 2023		Registration Fee Notice Sent
Submitted for opposition 42
on 7th Jun 2023		Advertised
Submitted for opposition 26
on 15th May 2023		Approved
Submitted for opposition 27
on 15th May 2023		Approval Notice Sent
Submitted for opposition 22
on 10th Feb 2023		Search Recorded
Submitted for opposition 20
on 10th Feb 2023		Examiner's First Report
Submitted for opposition 31
on 7th Mar 2019		Formalized
Submitted for opposition 1
on 6th Mar 2019		Created
Submitted for opposition 30
on 5th Mar 2019		Filed